HSHuibin Song

Huibin Song

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Huibin Song has a total of 15 co-authors. Here are the top co-authors by number of shared publications:

  • Chen Lin

    Department of Ophthalmology, Shenzhen People’s Hospital (The First Affiliated Hospital, Southern University of Science and Technology; The Second Clinical Medical College, Jinan University)

    1 shared publication
  • Chengyue Zhang

    Department of Ophthalmology, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health

    1 shared publication
  • Di Cao

    Department of Ophthalmology, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health

    1 shared publication
  • Fuhua Zhong

    Department of Thoracic Surgery, Shenzhen People’s Hospital (The First Affiliated Hospital, Southern University of Science and Technology; The Second Clinical Medical College, Jinan University)

    1 shared publication
  • Fuhua Zhong

    Department of Central Laboratory, Shenzhen People’s Hospital (The First Affiliated Hospital, Southern University of Science and Technology; The Second Clinical Medical College, Jinan University), Shenzhen 518020, China

    1 shared publication
  • Guangsuo Wang

    Shenzhen People's Hospital, Second Affiliated Hospital, Medical College of Ji'nan University, Shenzhen 518020, China

    1 shared publication

Latest Publications

  • Open Access

    BIRC5 drives cell-cycle dysregulation and represents a novel molecular target in retinoblastoma

    by Yingtong Chen, Xiaohan Li, Fuhua Zhong, Xiaoya Wang, Qiang Wang, Di Cao, Shaowei Dong, Chengyue Zhang, Huibin Song, Chen Lin

    Aims and objectives: Retinoblastoma is the most common pediatric intraocular malignancy, although it remains a rare disease overall, yet the molecular targets and therapeutic vulnerabilities sustaining its most aggressive proliferative cell states remain incompletely defined. We aimed to identify actionable molecular regulators and potential therapeutic targets of malignant retinoblastoma progression using integrated single-cell transcriptomics and functional validation. Methods: We analyzed single-cell RNA sequencing data from 189,431 cells derived from 13 retinoblastoma tumors and 3 normal fetal retina samples. Data integration was performed using Harmony, followed by clustering, differential expression, and functional enrichment analyses. BIRC5 function was evaluated through overexpression and siRNA-mediated knockdown in retinoblastoma cell lines (Y79, WERI-Rb1), with assessment of proliferation, migration, invasion, and cell cycle–related proteins. Results: Clustering identified 10 retinal cell types, including cone precursor-like, cone-like, and two MKI67 + proliferative RB subpopulations enrichment of G2/M-phase genes and chromosomal instability pathways. MKI67 + cells2 displayed hyperactivated cell cycle genes, chromosomal instability, and mitotic checkpoint dysregulation. BIRC5 (survivin) was selectively overexpressed in 93.7% of MKI67 + cells2 (mean expression 1.733 ± 0.643), while minimally expressed in other retinal cells. Functional assays demonstrated that BIRC5 overexpression promoted proliferation, invasion, migration, and CCND1/CDK4 activation, while suppressing CHEK2–p21–mediated checkpoint control. Conversely, BIRC5 knockdown induced G1 cell cycle arrest and increased apoptotic activity, accompanied by activation of checkpoint pathways. Conclusion: This study defines BIRC5 as a cell-state–specific regulator of malignant proliferation in retinoblastoma and provides a mechanistic rationale for targeting survivin in highly proliferative tumor subpopulations.

  • Open Access

    Single-Cell Dissection Identifies METTL7B as Associated with Cell Adhesion-Mediated Tumor Invasion in Lung Adenocarcinoma and Glioblastoma

    by Jie Mao, Jinquan Xia, Huibin Song, Fuhua Zhong, Huiyi Feng, Junhui Chen, Guangsuo Wang

    Background: Tumor invasion is the central barrier to effective immunotherapy in lung adenocarcinoma (LUAD) and glioblastoma. Cell adhesion signaling critically shapes tumor–microenvironment interactions, yet the upstream regulators coordinating these invasive programs at single-cell resolution remain incompletely understood. Methyltransferase Like protein 7B (METTL7B) has recently emerged as a candidate oncogenic regulator, but its lineage-specific functions and the potential downstream effectors are unclear. Methods: We integrated publicly available single-cell RNA sequencing datasets from LUAD and glioblastoma with The Cancer Genome Atlas (TCGA) transcriptomic analyses to resolve METTL7B-associated malignant cell states and microenvironmental interactions. Functional enrichment analyses identified invasion- and focal adhesion pathways linked to METTL7B expression. Gain- and loss-of-function experiments were conducted in LUAD and glioblastoma cell lines to validate downstream cell adhesion effectors. Spatial expression patterns were examined using immunofluorescence, and transwell assays were used to assess migratory and invasive phenotypes. Results: Single-cell analyses revealed that METTL7B was selectively enriched in malignant epithelial cells in LUAD and glioblastoma and defined a transcriptional program characterized by cell adhesion signaling. Integrin Alpha 3 (ITGA3) emerged as a conserved downstream effector of METTL7B, with progressive upregulation from minimally invasive to invasive LUAD and glioblastoma. Functional perturbation confirmed that METTL7B enhances tumor cell migration and invasion through integrin-associated pathways. Conclusions: METTL7B acts as a potential lineage-enriched regulator of invasive tumor states by activating cell adhesion signaling in LUAD and glioblastoma. These findings position METTL7B as a putative prognostic factor for strategies aimed at limiting invasion in lung cancer and glioblastoma.